Group A | Group B | ||
---|---|---|---|
Patients (n) 35 | Patients (n) 62 | ||
Gender | Gender | ||
Male | 21 (60%) | Male | 38 (61.3%) |
Female | 14 (40%) | Female | 24 (38.7%) |
Age at diagnosis (years) | Age at diagnosis (years) | ||
Range | 0.01–2.43 | Range | 0.06–17.68 |
Mean | 0.42 (SD 0.62) | Mean | 4.07 (SD 4.38) |
Age at follow-up (years) | Age at follow-up (years) | ||
Range | 0.01–2.43 | Range | 3.15–19.46 |
Mean | 1.47 (SD 0.81) | Mean | 9.82 (SD 4.59) |
Length of hospitalization (days) | Length of hospitalization (days) | ||
Range | 6–492 | Range | 5–153 |
Mean | 39.26 (SD 83.65) | Mean | 30.21 (SD 24.33) |
Type of ACNS infection | Type of ACNS infection | ||
Meningitis | 22 (62.9%) | Meningitis | 38 (62.9%) |
Meningoencephalitis | 7 (20%) | Meningoencephalitis | 15 (24.2%) |
Encephalitis | 5 (14.3%) | Encephalitis | 3 (4.8%) |
Cerebellitis | 1 (2.8%) | Cerebellitis | 5 (8.1%) |
Pathogens (n,%) | Pathogens (n,%) | ||
SP | 2 (5.7%) | SP | 16 (25.8%) |
SA | 4 (11.4%) | SA | 3 (4.8%) |
NM | 4 (11.4%) | NM | 16 (25.8%) |
HI | 3 (8.6%) | HI | 4 (6.4%) |
EC | 1 (2.8%) | E. Coli | 1 (1.6%) |
EV | 11 (31.4%) | Enterovirus | 6 (9.7%) |
HHV6 | 5 (14.3%) | HHV6 | 3 (4.8%) |
EBV | 2 (5.7%) | EBV | 4 (6.4%) |
HSV1 | 1 (2.8%) | HSV1 | 1 (1.6%) |
TBC | 2 (5.7%) | TBC | 6 (9.7%) |
KP | 0 (0%) | K. Pneumoniae | 1 (1.6%) |